1. Home
  2. BWAY vs AMCX Comparison

BWAY vs AMCX Comparison

Compare BWAY & AMCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWAY
  • AMCX
  • Stock Information
  • Founded
  • BWAY 2003
  • AMCX 1980
  • Country
  • BWAY Israel
  • AMCX United States
  • Employees
  • BWAY N/A
  • AMCX N/A
  • Industry
  • BWAY Medical/Dental Instruments
  • AMCX Cable & Other Pay Television Services
  • Sector
  • BWAY Health Care
  • AMCX Telecommunications
  • Exchange
  • BWAY Nasdaq
  • AMCX Nasdaq
  • Market Cap
  • BWAY 280.7M
  • AMCX 312.4M
  • IPO Year
  • BWAY 2019
  • AMCX 2011
  • Fundamental
  • Price
  • BWAY $14.97
  • AMCX $7.78
  • Analyst Decision
  • BWAY Strong Buy
  • AMCX Sell
  • Analyst Count
  • BWAY 2
  • AMCX 5
  • Target Price
  • BWAY $18.00
  • AMCX $6.50
  • AVG Volume (30 Days)
  • BWAY 61.1K
  • AMCX 389.7K
  • Earning Date
  • BWAY 11-11-2025
  • AMCX 11-07-2025
  • Dividend Yield
  • BWAY N/A
  • AMCX N/A
  • EPS Growth
  • BWAY 679.98
  • AMCX N/A
  • EPS
  • BWAY 0.11
  • AMCX N/A
  • Revenue
  • BWAY $46,084,000.00
  • AMCX $2,354,176,000.00
  • Revenue This Year
  • BWAY $335.63
  • AMCX N/A
  • Revenue Next Year
  • BWAY $22.10
  • AMCX N/A
  • P/E Ratio
  • BWAY $55.30
  • AMCX N/A
  • Revenue Growth
  • BWAY 26.50
  • AMCX N/A
  • 52 Week Low
  • BWAY $7.84
  • AMCX $5.41
  • 52 Week High
  • BWAY $17.00
  • AMCX $10.60
  • Technical
  • Relative Strength Index (RSI)
  • BWAY 48.22
  • AMCX 48.12
  • Support Level
  • BWAY $14.65
  • AMCX $7.77
  • Resistance Level
  • BWAY $15.60
  • AMCX $8.16
  • Average True Range (ATR)
  • BWAY 0.67
  • AMCX 0.31
  • MACD
  • BWAY -0.11
  • AMCX -0.09
  • Stochastic Oscillator
  • BWAY 29.79
  • AMCX 1.99

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

About AMCX AMC Networks Inc.

AMC Networks owns several linear pay-TV networks, including AMC, WE tv, BBC America, IFC, and SundanceTV. AMC, its most widely distributed network, reached 60 million pay-TV households in the US at the end of 2024. The firm also had nearly 12.5 million US streaming subscribers, with AMC+ as the flagship streaming platform. With both its linear networks and streaming offerings, the firm caters to specific niche audiences. Over the last 15 years, AMC has shifted its focus to original scripted programming from classic movies. It creates content through AMC Studios and also generates revenue from licensing content. Following an international divestiture at the end of 2023, domestic operations make up nearly 90% of total revenue.

Share on Social Networks: